FIELD: medicine.
SUBSTANCE: invention refers to methods and compositions for treatment and/or prevention maintenance of infectious condition in liquid-containing organ or organ with natural external aperture. Composition includes antibacterial agent, and also, probably, other active agents, amphipathic oil which is soluble in water and insoluble in ethanol, microcrystalline wax and pharmaceutically acceptable nonaqueous carrier. The method of treatment is realised by introduction of a pharmaceutical composition in body through natural external aperture.
EFFECT: regarding composition, invention provides stability of the active agent against oxidising decomposition, low interfacial tension of composition, easy solubility in liquids, and short time of excretion; invention provides effective treatment and reduction of by-effects and toxicity.
61 cl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DISPERSIBLE PREPARATION OF ANTIINFLAMMATION AGENT | 2004 |
|
RU2319508C2 |
| DISPERSIBLE PHARMACEUTICAL COMPOSITIONS | 2003 |
|
RU2311201C2 |
| METHOD AND PHARMACEUTICAL COMPOSITION FOR ANTIPHLOGISTIC AGENT DELIVERY | 2004 |
|
RU2325189C2 |
| DISPERSIBLE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF MASTITIS AND OTIC DISORDERS | 2004 |
|
RU2321423C2 |
| CRYSTALLINE FREE CEFTHIOFURIC ACID, COMPOSITION ON SAID AND METHOD OF ITS SYNTHESIS | 1994 |
|
RU2136685C1 |
| OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF | 1998 |
|
RU2215740C2 |
| BICYCLIC OXAZINE- OR THIAZINE-OXAZOLIDINONES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND METHODS OF TREATMENT OF PATIENTS WITH MICROBIAL INFECTIONS | 1995 |
|
RU2128660C1 |
| PHARMACEUTICAL TABLET | 2003 |
|
RU2273473C2 |
| NEW TREATMENT | 2015 |
|
RU2688191C2 |
| METHODS FOR MEASUREMENT OF DISSOLVING RATE OF ANALYZED SUBSTANCE IN NONAQUEOUS LIQUID COMPOSITION | 2003 |
|
RU2300766C2 |
